From Name:
From Email:
To Name:
To Email:

Optional Message:

High-dose Tirofiban During PCI is Associated With Significant Reduction in All-cause Mortality

from Cardiovascular Business

A meta-analysis of 41 randomized clinical trials found that patients who received high-dose bolus tirofiban during percutaneous coronary intervention had a significant reduction in all-cause mortality compared with those who received eptifibatide or heparin. There were no significant differences between the anticoagulation strategies with regards to myocardial infarction, major bleeding or major adverse cardiovascular events. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063